Vyome Holdings (HIND) Non-Current Assets (2015 - 2026)
Vyome Holdings (HIND) posted quarterly Non-Current Assets of $1.0 million for Q1 2026, up 121.08% year-over-year from $462663.5 in Q1 2025, and down 3.4% quarter-over-quarter from $1.1 million in Q4 2025.
Vyome Holdings (HIND) Non-Current Assets (2015 - 2026) Analysis & Trends
Vyome Holdings' Non-Current Assets history runs 12 years deep, the most recent figure standing at $1.0 million for Q1 2026.
- In Q1 2026, Non-Current Assets rose 121.08% year-over-year to $1.0 million; the TTM figure through Mar 2026 stood at $1.0 million (up 112.37% YoY), while the FY2025 annual figure was $1.1 million, down 1.91% from the prior year.
- Non-Current Assets for Q1 2026 stood at $1.0 million, down from $1.1 million in the prior quarter.
- The five-year high for Non-Current Assets was $22.3 million in Q1 2022, with the low at -$4.9 million in Q1 2025.
- The 5-year median for Non-Current Assets is $1.0 million (2026), against an average of $3.4 million.
- The sharpest annual moves came in 2022 and 2025: Non-Current Assets jumped 390.48% in 2022, then slumped 1544.02% in 2025.
- Vyome Holdings' Non-Current Assets stood at $1.2 million in 2022, then slumped by 70.19% to $367000.0 in 2023, then surged by 194.15% to $1.1 million in 2024, then slipped by 1.91% to $1.1 million in 2025, then slipped by 3.4% to $1.0 million in 2026.
- Business Quant data shows HIND's Non-Current Assets at $1.0 million in Q1 2026, $1.1 million in Q4 2025, and $1.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 14.88 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 23.28 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 1.96 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 5.15 Bn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 1.96 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 938.60 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 468.65 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 18.06 Bn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 6.80 Bn |
| 10 | Vyome Holdings | 16.00 Mn | 8.11 Mn | 11,658.00 | 1.02 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.02 Mn |
| Mar 31, 2026 | 1.02 Mn |
| Dec 31, 2025 | 1.06 Mn |
| Sep 30, 2025 | 1.01 Mn |
| Jun 30, 2025 | 166,000.00 |
| Mar 31, 2025 | -4.85 Mn |
| Dec 31, 2024 | 1.08 Mn |
| Sep 30, 2024 | -4.06 Mn |
| Jun 30, 2024 | 306,000.00 |
| Mar 31, 2024 | 336,000.00 |
| Dec 31, 2023 | 367,000.00 |
| Sep 30, 2023 | 428,000.00 |
| Jun 30, 2023 | 1.31 Mn |
| Mar 31, 2023 | 1.12 Mn |
| Dec 31, 2022 | 1.23 Mn |
| Sep 30, 2022 | 13.23 Mn |
| Jun 30, 2022 | 21.19 Mn |
| Mar 31, 2022 | 22.31 Mn |
| Dec 31, 2021 | 22.59 Mn |
| Sep 30, 2021 | 53.52 Mn |